Arzu Yılmaztepe Oral

The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested

Engı̇n Ulukaya, Özdikicioglu Ferda, Arzu Yılmaztepe Oral et al. · Toxicology in Vitro · 2007 · 189 citations

Growth Hormone, Biochemistry, Lower Result +8

Promising anti-growth effects of palladium(II) saccharinate complex of terpyridine by inducing apoptosis on transformed fibroblasts in vitro

Melis Debreli Coskun, Arzu Yılmaztepe Oral, Mehmet Sarımahmut et al. · Bioorganic & Medicinal Chemistry · 2013 · 68 citations

Medicinal Chemistry, Anti-growth Effects, Biochemistry +11

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease

Yusuf Yılmaz, Engı̇n Ulukaya, Özen Öz Gül et al. · Clinical Biochemistry · 2009 · 65 citations

Metabolic Syndrome, Hepatology, Nonalcoholic Fatty Liver Disease +11

The involvement of IL‐10, IL‐6, IFN‐<i>γ</i>, TNF‐<i>α</i> and TGF‐<i>β</i> gene polymorphisms among Turkish lung cancer patients

Mukaddes Çolakoğulları, Engı̇n Ulukaya, Arzu Yılmaztepe Oral et al. · Cell Biochemistry and Function · 2007 · 65 citations

Serum fetuin A/<i>α</i>2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis

Yusuf Yılmaz, Oya Yönal, Ramazan Kurt et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2010 · 61 citations · Full text